Neuro-oncology: new hope for patients with gliomas

被引:1
作者
DeAngelis, Lisa M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
关键词
RECURRENT GLIOBLASTOMA; BEVACIZUMAB; MUTATIONS; SURVIVAL; TRIAL; IDH1;
D O I
10.1016/S1474-4422(09)70326-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:17 / 18
页数:2
相关论文
共 8 条
  • [1] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    Friedman, Henry S.
    Prados, Michael D.
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Huang, Jane
    Zheng, Maoxia
    Cloughesy, Timothy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4733 - 4740
  • [2] Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial
    Gehring, Karin
    Sitskoorn, Margriet M.
    Gundy, Chad M.
    Sikkes, Sietske A. M.
    Klein, Martin
    Postma, Tjeerd J.
    van den Bent, Martin J.
    Beute, Guus N.
    Enting, Roelien H.
    Kappelle, Arnoud C.
    Boogerd, Willem
    Veninga, Theo
    Twijnstra, Albert
    Boerman, Dolf H.
    Taphoorn, Martin J. B.
    Aaronson, Neil K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : 3712 - 3722
  • [3] Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
    Iwamoto, F. M.
    Abrey, L. E.
    Beal, K.
    Gutin, P. H.
    Rosenblum, M. K.
    Reuter, V. E.
    DeAngelis, L. M.
    Lassman, A. B.
    [J]. NEUROLOGY, 2009, 73 (15) : 1200 - 1206
  • [4] Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor-Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
    Kamoun, Walid S.
    Ley, Carsten D.
    Farrar, Christian T.
    Duyverman, Annique M.
    Lahdenranta, Johanna
    Lacorre, Delphine A.
    Batchelor, Tracy T.
    di Tomaso, Emmanuelle
    Duda, Dan G.
    Munn, Lance L.
    Fukumura, Dai
    Sorensen, A. Gregory
    Jain, Rakesh K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2542 - 2552
  • [5] Bevacizumab and chemotherapy for recurrent glioblastoma A single-institution experience
    Nghiemphu, P. L.
    Liu, W.
    Lee, Y.
    Than, T.
    Graham, C.
    Lai, A.
    Green, R. M.
    Pope, W. B.
    Liau, L. M.
    Mischel, P. S.
    Nelson, S. F.
    Elashoff, R.
    Cloughesy, T. F.
    [J]. NEUROLOGY, 2009, 72 (14) : 1217 - 1222
  • [6] Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    Stupp, Roger
    Hegi, Monika E.
    Mason, Warren P.
    van den Bent, Martin J.
    Taphoorn, Martin J. B.
    Janzer, Robert C.
    Ludwin, Samuel K.
    Allgeier, Anouk
    Fisher, Barbara
    Belanger, Karl
    Hau, Peter
    Brandes, Alba A.
    Gijtenbeek, Johanna
    Marosi, Christine
    Vecht, Charles J.
    Mokhtari, Karima
    Wesseling, Pieter
    Villa, Salvador
    Eisenhauer, Elizabeth
    Gorlia, Thierry
    Weller, Michael
    Lacombe, Denis
    Cairncross, J. Gregory
    Mirimanoff, Rene-Olivier
    [J]. LANCET ONCOLOGY, 2009, 10 (05) : 459 - 466
  • [7] IDH1 and IDH2 Mutations in Gliomas
    Yan, Hai
    Parsons, D. Williams
    Jin, Genglin
    McLendon, Roger
    Rasheed, B. Ahmed
    Yuan, Weishi
    Kos, Ivan
    Batinic-Haberle, Ines
    Jones, Sian
    Riggins, Gregory J.
    Friedman, Henry
    Friedman, Allan
    Reardon, David
    Herndon, James
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Vogelstein, Bert
    Bigner, Darell D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08) : 765 - 773
  • [8] Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
    Zhao, Shimin
    Lin, Yan
    Xu, Wei
    Jiang, Wenqing
    Zha, Zhengyu
    Wang, Pu
    Yu, Wei
    Li, Zhiqiang
    Gong, Lingling
    Peng, Yingjie
    Ding, Jianping
    Lei, Qunying
    Guan, Kun-Liang
    Xiong, Yue
    [J]. SCIENCE, 2009, 324 (5924) : 261 - 265